Cellular determinants and therapeutic implications of inflammation in pancreatic cancer
Author:
Funder
National Institutes of Health
Stand Up to Cancer
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference152 articles.
1. A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer;Aglietta;Annals of Oncology,2014
2. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice;Albrengues;Science,2018
3. Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: A multicenter study;Anderson;The American Journal of Gastroenterology,2012
4. Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC;Antonia;The New England Journal of Medicine,2018
5. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer;Antonia;The New England Journal of Medicine,2017
Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The tumor immune microenvironment in resected treatment-naive pancreatic cancer patients with long-term survival;Pancreatology;2024-08
2. Zebrafish model and network pharmacology integrated to investigate the possible therapeutic targets of 6′-O-Caffeoylarbutin on anti-inflammatory;South African Journal of Botany;2024-08
3. The prognostic role of lymphocyte-to-monocyte ratio in patients with resectable pancreatic cancer: a systematic review and meta-analysis;PeerJ;2024-07-18
4. The causal effects of immune cells on pancreatic cancer: A 2‑sample Mendelian randomization study;Medicine;2024-04-19
5. Hepatocytes coordinate immune evasion in cancer via release of serum amyloid A proteins;Nature Immunology;2024-04-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3